This study investigates aliskiren, the first in a new antihypertensive class called renin inhibitors.

本试验中所研究的阿利克伦是新一类降压药-肾素抑制剂的首种药物.

互联网

Objecties: This dose - ranging study evaluated the antihypertensive efficacy and tolerability aliskiren in patients with mild - to - moderate hypertension.

目的: 本研究是评估阿利克伦在轻中度高血压患者中的有效及耐受剂量范围.

互联网